$1.21 EPS Expected for Spirit AeroSystems Holdings, Inc. (SPR), 2 Analysts Bullish Catalyst Pharmaceuticals (CPRX)

July 21, 2017 - By Vivian Currie

Among 2 analysts covering Catalyst Pharmaceuticals (NASDAQ:CPRX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Catalyst Pharmaceuticals had 3 analyst reports since April 26, 2016 according to SRatingsIntel. The firm earned “Overweight” rating on Wednesday, October 5 by PiperJaffray. The firm has “Overweight” rating given on Wednesday, October 5 by Piper Jaffray. On Tuesday, April 26 the stock rating was downgraded by Piper Jaffray to “Neutral”. See Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) latest ratings:

Analysts expect Spirit AeroSystems Holdings, Inc. (NYSE:SPR) to report $1.21 EPS on August, 2.They anticipate $0.00 EPS change or 0.00% from last quarter’s $1.21 EPS. SPR’s profit would be $145.45M giving it 12.55 P/E if the $1.21 EPS is correct. After having $1.17 EPS previously, Spirit AeroSystems Holdings, Inc.’s analysts see 3.42% EPS growth. About 104,638 shares traded. Spirit AeroSystems Holdings, Inc. (NYSE:SPR) has risen 15.24% since July 21, 2016 and is uptrending. It has underperformed by 1.46% the S&P500.

Spirit AeroSystems Holdings, Inc. is a non-original equipment maker , aircraft parts designer and maker of commercial aero-structures. The company has market cap of $7.30 billion. The Firm is also a supplier of aero-structures. It has a 17.01 P/E ratio. The Firm operates through three divisions: Fuselage Systems, Propulsion Systems and Wing Systems.

Among 16 analysts covering Spirit Aerosystems (NYSE:SPR), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Spirit Aerosystems had 29 analyst reports since July 30, 2015 according to SRatingsIntel. As per Friday, January 15, the company rating was upgraded by Credit Suisse. RBC Capital Markets initiated Spirit AeroSystems Holdings, Inc. (NYSE:SPR) on Thursday, January 12 with “Underperform” rating. The stock has “Outperform” rating by Bernstein on Tuesday, January 5. The firm has “Sector Perform” rating by RBC Capital Markets given on Thursday, July 30. The stock of Spirit AeroSystems Holdings, Inc. (NYSE:SPR) earned “Sell” rating by RBC Capital Markets on Monday, June 5. RBC Capital Markets maintained the shares of SPR in report on Friday, July 7 with “Sell” rating. The stock of Spirit AeroSystems Holdings, Inc. (NYSE:SPR) earned “Sell” rating by Goldman Sachs on Friday, January 29. The firm has “Neutral” rating by Buckingham Research given on Thursday, June 9. The firm earned “Hold” rating on Monday, December 5 by Deutsche Bank. UBS upgraded Spirit AeroSystems Holdings, Inc. (NYSE:SPR) rating on Tuesday, May 9. UBS has “Buy” rating and $63 target.

Investors sentiment increased to 1.34 in 2016 Q4. Its up 0.57, from 0.77 in 2016Q3. It is positive, as 23 investors sold Spirit AeroSystems Holdings, Inc. shares while 96 reduced holdings. 68 funds opened positions while 92 raised stakes. 118.30 million shares or 2.49% less from 121.32 million shares in 2016Q3 were reported. Lazard Asset Management Ltd Liability Co has 0.02% invested in Spirit AeroSystems Holdings, Inc. (NYSE:SPR) for 138,514 shares. Northern Corporation owns 0.01% invested in Spirit AeroSystems Holdings, Inc. (NYSE:SPR) for 683,730 shares. Amalgamated Bank accumulated 19,386 shares. Tower Rech Capital Limited Liability Corp (Trc) invested in 0% or 227 shares. Art Ltd Llc holds 0.24% of its portfolio in Spirit AeroSystems Holdings, Inc. (NYSE:SPR) for 68,000 shares. Nationwide Fund Advsrs reported 284,504 shares. Carroll Fincl Assocs reported 150 shares or 0% of all its holdings. Intrust Commercial Bank Na accumulated 56,482 shares or 1.25% of the stock. Pictet And Cie (Europe) Sa has invested 0.15% in Spirit AeroSystems Holdings, Inc. (NYSE:SPR). Allianz Asset Ag has 578,051 shares for 0.03% of their portfolio. The Georgia-based Invesco Limited has invested 0.01% in Spirit AeroSystems Holdings, Inc. (NYSE:SPR). Bluemountain Cap Mngmt Ltd Limited Liability Company has invested 0.02% in Spirit AeroSystems Holdings, Inc. (NYSE:SPR). Utd Capital Fincl Advisers Lc owns 19,608 shares. Fuller & Thaler Asset Mngmt Incorporated stated it has 0% in Spirit AeroSystems Holdings, Inc. (NYSE:SPR). 5.50 million are held by Darsana Capital Ltd Partnership.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.64, from 0.3 in 2016Q3. It improved, as 6 investors sold Catalyst Pharmaceuticals Inc shares while 12 reduced holdings. 9 funds opened positions while 8 raised stakes. 23.81 million shares or 1.65% more from 23.42 million shares in 2016Q3 were reported. Provise Mngmt Group Limited Liability Com holds 19,000 shares. Kcg Inc owns 54,200 shares for 0% of their portfolio. Blackrock Institutional Trust Na owns 469,440 shares or 0% of their US portfolio. Guggenheim Cap Ltd holds 21,335 shares. Walleye Trading Ltd Limited Liability Company holds 0% of its portfolio in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) for 1,900 shares. National Bank Of Mellon Corp reported 0% stake. 500 are owned by Cwm Limited Liability Corporation. California Employees Retirement Sys holds 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) or 41,332 shares. Venbio Select Advisor Limited Liability Co owns 1.14 million shares. Two Sigma reported 11,603 shares. 2.27 million are held by Point72 Asset Mngmt L P. Art Ltd Liability Corporation holds 63,300 shares or 0% of its portfolio. Financial Bank Of America De invested 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Oxford Asset Management accumulated 24,759 shares. Morgan Stanley accumulated 12,419 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.